VeraDermics

Forecast & Rating7 analysts currently cover VeraDermics, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $163.50, about 49.3% upside from the current price of $109.51. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study VeraDermics closely still see room for the stock to rise. Data as of Jul 21, 2026; for reference only and not investment advice.